Navigation Links
Dr Reddy’s Laboratories launches Hyalosy

The Hyderabad-based Dr Reddy’s Laboratories has launched Hyalosyn (sodium hyaluronate), an intra-articular injection that provides relief from knee-joint stiffness and immobility among patients suffering from severe osteoarthritis. Osteoarthritis is a widely prevalent disease. More than 90 per cent of people above the age of 45 are estimated to show signs of this disease, and it is the leading cause of disability in people above the age of 65. //

Hyaluronic acid, the active substance in Hyalosyn, a naturally occurring substance found in Synovial fluid, surrounds the joints. Hyaluronic acid acts as a lubricant that enables bones to move smoothly over each other and also acts as a shock absorber for joints. Hyalosyn is an emerging therapy for osteoarthritis. Hyalosyn will provide the much-needed relief to patients suffering from severe osteoarthritis and will enable them to resume their daily activities.

Hyalosyn will be marketed as a sterile, pre-filled syringe containing 20 mg/2ml of sodium hyaluronate. Hyalosyn is being launched under a co-marketing arrangement with Gland Pharma, a pharmaceutical company in Hyderabad well known for the production of pre-filled injectables. The introduction of Hyalosyn would further strengthen the company’s arthritis franchise in which it is already a leading player in the domestic market.
'"/>




Page: 1

Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru
3. Dr Reddy’s Laboratories to challenge patents on drug
4. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
5. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
6. Abbott’s Laboratories R&D Capabilities Questione
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. ICMR to Set up Laboratories to Combat Bird Flu
9. Ranbaxy Laboratories to Be Aided in Drug Research
10. Bangladesh to Set Up HIV/AIDS Diagnosis Laboratories
11. Glaxo launches pills to help smokers quit in 7-12 weeks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
Breaking Medicine Technology: